TNDM News and Press, Tandem Diabetes Care Inc. From 02/23/26

2026-02-23 18:33:18 ET Denver, Colorado - Midday trading is being shaped by a powerful mix of biotech momentum, breakthrough materials science, and strategic buyouts, as investors rotate toward companies delivering tangible catalysts. Spider Silk Headlines Power Materials Story ...

2026-02-23 16:12:42 ET More on Tandem Diabetes Care Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition Tandem Diabetes Care, Inc. (TNDM) Q4 2025 Earnings Call Transcript Tandem Diabetes Care, Inc. 2025 Q4 - Results - Earnings Call Presentation ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions and other factors, $200.0 million aggregate principal amount of its Convertible Senior Notes due 2032 (the “notes...

2026-02-23 11:58:36 ET Thesis Tandem Diabetes Care, Inc. ( TNDM ) beat out expectations in Q4 '25. GAAP EPS came in at -$0.01, which was actually $0.05 above the consensus. Elsewhere, revenue for the quarter hit $290.4 million, up about 2.8% year-over-year and $13.16 million...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 2.9% to $1.7 on volume of 757,322,225 shares Mangoceuticals Inc. (MGRX) rose 48.8% to $0.53 on volume of 349,214,525 shares Rackspace Technology Inc. (RXT) rose 37.1% to $1.68 on v...

2026-02-20 22:19:10 ET Shares of Tandem Diabetes Care (NASDAQ: TNDM) leaped on Friday after the insulin delivery specialist reported significant gains in profitability. By the close of trading, Tandem's stock price was up more than 32%. Image source: Getty Images. Cont...

2026-02-20 08:04:04 ET from Mizuho Securities issued a price target of $22.00 for TNDM on 2026-02-20 12:33:05. The adjusted price target was set to $22.00. At the time of the announcement, TNDM was trading at $18.52. The overall price target consensus is at $25.10 with h...

2026-02-20 07:15:04 ET UBS analyst issues NEUTRAL recommendation for TNDM on February 20, 2026 12:09PM ET. The previous analyst recommendation was Neutral. TNDM was trading at $18.52 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current...

2026-02-20 02:25:36 ET More on Tandem Diabetes Care Tandem Diabetes Care, Inc. 2025 Q4 - Results - Earnings Call Presentation Tandem Diabetes rises following Q4 earnings beats Tandem upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026 Seekin...

2026-02-20 02:24:58 ET Tandem Diabetes Care, Inc. (TNDM) Q4 2025 Earnings Call February 19, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Tandem Diabetes Care, Inc. (TNDM) Q4 2025 Earnings Call Transcript